Sponsor Pipeline

Philogen S.p.A. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
15
Active Trials
10
Recruiting
2
Phase 3
6
Disease Areas
5
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-01 NCT07227350
L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC)
Trial sites expanded: 3 -> 18 locations
2026-07-22 NCT07228442
L19IL2/L19TNF in Patients With Cutaneous Squamous Cell Carcinoma
Recruitment opened
2026-07-22 NCT07228442
L19IL2/L19TNF in Patients With Cutaneous Squamous Cell Carcinoma
Trial sites expanded: 2 -> 19 locations
2026-07-22 NCT07227870
L19IL2/TNF in Patients With Basal Cell Carcinoma
Recruitment opened
2026-07-22 NCT07227870
L19IL2/TNF in Patients With Basal Cell Carcinoma
Trial sites expanded: 3 -> 18 locations
Active Trials by Phase
Phase 3
2
Phase 2
7
Phase 1/2
1
Phase 1
5
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT03567889 Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D… Melanoma Stage IIIB Recruiting
NCT02938299 Neoadjuvant L19IL2/L19TNF- Pivotal Study Malignant Melanoma Active, Not Recruiting
Phase 2
NCT06284590 Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination… Melanoma Stage III Recruiting
NCT07227870 L19IL2/TNF in Patients With Basal Cell Carcinoma Locally Advanced Basal Cell Carcinoma Recruiting
NCT07228442 L19IL2/L19TNF in Patients With Cutaneous Squamous Cell Carcinoma Locally Advanced Cutaneous Squamous Cell Carcinoma Recruiting
NCT07227350 L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC) Locally Advanced Basal Cell Carcinoma Recruiting
NCT04733183 Efficacy and Safety of L19TNF in Previously Treated Patients with Advanced Stage or… Soft Tissue Sarcoma Active, Not Recruiting
NCT07120984 A Study to Evaluate the Safety and Efficacy of L19TNF With Alkylating Chemotherapy for… Glioma Not Yet Recruiting
NCT06336291 A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at… Glioblastoma Active, Not Recruiting
Phase 1/2
NCT04443010 Safety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly… Glioblastoma Recruiting
Phase 1
NCT04471987 Safety and Early Signs of Efficacy of IL12-L19L19. Advanced Solid Tumor Recruiting
NCT06640413 A Study to Evaluate the Safety and Preliminary Signs of Efficacy of [177Lu]Lu-OncoFAP-23… FAP Recruiting
NCT07600554 A Phase I Study to Evaluate the Safety and Dosimetry of Imaging With 68Ga-OncoACP3 in… Prostate Cancer Recruiting
NCT07245992 A Study of F8IL10 Intra-articular Treatment in Rheumatoid Arthritis Rheumatoid Arthritis (RA) Recruiting
NCT07566897 A Phase I Study to Evaluate the Safety and Efficacy of L19IL2 in Combination With… Renal Carcinoma Metastatic Not Yet Recruiting
Disease Areas
Get alerts when Philogen S.p.A.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free